TECHNOVAX, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TECHNOVAX, INC..The latest application filed is for "recombinant circovirus capsid-virus-like particle (vlp): compositions, methods and uses".

Company Profile

7.17.14

TECHNOVAX, INC. - Elmsford NY
TechnoVax Inc. - Tarrytown NY US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Flavivirus and alpha virus virus-like particles (VLPS) Grant 11,389,522 - Galarza , et al. July 19, 2	2022-07-19
Recombinant Circovirus Capsid-virus-like Particle (vlp): Compositions, Methods And Uses App 20220177855 - GALARZA; Jose M. ; et al.	2022-06-09
Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine Grant 11,324,816 - Galarza , et al. May 10, 2	2022-05-10
Flavivirus And Alphavirus Virus-like Particles (vlps) App 20200397887 - GALARZA; Jose M. ; et al.	2020-12-24
Flavivirus and alphavirus virus-like particles (VLPS) Grant 10,799,575 - Galarza , et al. October 13, 2	2020-10-13
Universal Virus-like Particle (vlp) Influenza Vaccines App 20200297836 - Galarza; Jose M. ; et al.	2020-09-24
Universal virus-like particle (VLP) influenza vaccines Grant 10,695,418 - Galarza , et al.	2020-06-30
Universal Virus-like Particle (vlp) Influenza Vaccines App 20190091323 - GALARZA; Jose M. ; et al.	2019-03-28
Human Respiratory Syncytial Virus (hrsv) Virus-like Particles (vlps) Based Vaccine App 20190030156 - GALARZA; Jose M. ; et al.	2019-01-31
Inhalable vaccine compositions and methods Grant 10,159,644 - Smutney , et al. Dec	2018-12-25
Universal virus-like particle (VLP) influenza vaccines Grant 10,080,796 - Galarza , et al. September 25, 2	2018-09-25
Flavivirus And Alphavirus Virus-like Particles (vlps) App 20180177859 - GALARZA; Jose M. ; et al.	2018-06-28
Universal Virus-like Particle (vlp) Influenza Vaccines App 20160303223 - Galarza; Jose M. ; et al.	2016-10-20
Influenza virus-like particle (VLP) compositions Grant 9,387,241 - Galarza , et al. July 12, 2	2016-07-12
Universal virus-like particle (VLP) influenza vaccines Grant 9,352,031 - Galarza , et al. May 31, 2	2016-05-31
Polyvalent Influenza Virus-like Particle (vlp) Compositions App 20150299270 - Galarza; Jose M. ; et al.	2015-10-22
Inhalable Vaccine Compositions And Methods App 20150283069 - Smutney; Chad C. ; et al.	2015-10-08
Polyvalent influenza virus-like particle (VLP) compositions Grant 9,101,578 - Galarza , et al. August 11, 2	2015-08-11
Influenza Virus-like Particle (vlp) Compositions App 20140286992 - Galarza; Jose M. ; et al.	2014-09-25
Influenza virus-like particle (VLP) compositions Grant 8,778,353 - Galarza , et al. July 15, 2	2014-07-15
Universal virus-like particle (VLP) influenza vaccines App 20110212128 - Galarza; Jose M. ; et al.	2011-09-01

Company Registrations

NCAGE Code	4HCV5	TECHNOVAX, INC.
CAGE Code	4HCV5	TECHNOVAX, INC.
S.A.M. Registration	4HCV5 [361464907]	TECHNOVAX, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.